- Page 5 and 6: TABLE OF CONTENTSIntroduction .....
- Page 7 and 8: PART IITEM 1: IDENTITY OF DIRECTORS
- Page 9 and 10: (1) In accordance with U.S. GAAP, w
- Page 11 and 12: As of November 30,2005 2004 2003 20
- Page 13 and 14: Our quarterly operating results hav
- Page 15 and 16: incorporating, or using the open so
- Page 17 and 18: Our future growth depends in part o
- Page 19 and 20: We may incur expenses related to ob
- Page 21 and 22: of those controls. In the course of
- Page 23 and 24: Bermuda law whereby two corporate e
- Page 25 and 26: drives and over 20% of all 2.5 inch
- Page 27 and 28: capacity desktop disk drives into e
- Page 29 and 30: 250 gigabytes disk drives were ship
- Page 31 and 32: Strategic Relationships with Techno
- Page 33 and 34: Expanding Into Complementary Market
- Page 35 and 36: capable of providing detailed statu
- Page 37 and 38: Customer ContractsOur contractual r
- Page 39 and 40: we consider patent protection to be
- Page 41 and 42: generated from sales to customers i
- Page 43 and 44: OverviewWe are a leading provider o
- Page 45 and 46: in these revenues over recent fisca
- Page 47 and 48: As of November 30, 2005, 27% of our
- Page 49 and 50: Results from Continuing OperationsT
- Page 51 and 52: The $123.9 million increase in reve
- Page 53 and 54:
Provision (Benefit) for Income Taxe
- Page 55 and 56:
track writers and the contribution
- Page 57 and 58:
Net Loss from Continuing Operations
- Page 59 and 60:
size, timing and fluctuations of cu
- Page 61 and 62:
Net cash used in investing activiti
- Page 63 and 64:
Although we believe that our judgme
- Page 65 and 66:
expected term. In October 2005, the
- Page 67 and 68:
During our 2005 fiscal year Paul Ha
- Page 69 and 70:
performance criteria by the individ
- Page 71 and 72:
The following table shows the numbe
- Page 73 and 74:
At January 31, 2006, no performance
- Page 75 and 76:
the shares subject to a purchase ri
- Page 77 and 78:
on the date of grant of the option
- Page 79 and 80:
agreements total $3.5million. The t
- Page 81 and 82:
ITEM 10: ADDITIONAL INFORMATIONItem
- Page 83 and 84:
an average of the quarterly values
- Page 85 and 86:
ITEM 11: QUANTITATIVE AND QUALITATI
- Page 87 and 88:
Item 16A: Audit Committee Financial
- Page 89 and 90:
PART IIIITEM 17: FINANCIAL STATEMEN
- Page 91 and 92:
XYRATEX LTDREPORT OF INDEPENDENT RE
- Page 93 and 94:
XYRATEX LTDAUDITED CONSOLIDATED STA
- Page 95 and 96:
XYRATEX LTDAUDITED CONDENSED CONSOL
- Page 97 and 98:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 99 and 100:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 101 and 102:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 103 and 104:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 105 and 106:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 107 and 108:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 109 and 110:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 111 and 112:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 113 and 114:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 115 and 116:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 117 and 118:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 119 and 120:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 121 and 122:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 123 and 124:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 125 and 126:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 127 and 128:
XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 129 and 130:
XYRATEX LTDNOTES TO AUDITED CONSOLI